LI

Life Stem Genetics IncOOTC LIFS Stock Report

Last reporting period 31 Mar, 2014

Updated 31 Jul, 2023

Last price

Market cap $B

0

Micro

Exchange

OOTC - OTC

LIFS Stock Analysis

LI

Uncovered

Life Stem Genetics Inc is uncovered by Eyestock quantitative analysis.

Market cap $B

0

Dividend yield

Shares outstanding

45.84 B

Website

Life Stem Genetics, Inc. engages in the operation of stem cell therapy-based clinics. The company is headquartered in Beverly Hills, California and currently employs 1 full-time employees. The company went IPO on 2013-04-11. The firm intends to offer their treatments through a series of affiliate doctors, and medical clinics, with approximately 60 affiliated clinics. The Stem Cells heal various ailments and are being offered as a way to treat various illnesses ranging from orthopedic injuries, neurological disorders, such as Parkinson's, Alzheimer's, Cancer, Plastic Surgery, Age Management, Arthritis, Diabetes, Cardiology, Chronic Obstructive Pulmonary Disease, Multiple Sclerosis and Urology. LISF's Stem Cell Therapy and techniques help to repair or re-program damaged or diseased tissues and organs.

View Section: Eyestock Rating